Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) — Cash Flow Reinvestment Rate
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Cash Flow Reinvestment Rate of 0.18x as of September 2024, reinvesting TL5.93 Million (capex TL2.91 Million plus investments TL-3.03 Million) from operating cash flow of TL33.37 Million. Explore ONCSM capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Cash Flow Reinvestment Rate (2020–2022)
Historical reinvestment intensity for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. across 3 annual periods. Also explore Oncosem Onkolojik Sistemler Sanayi ve Ti assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2022)
Year-by-year capital reinvestment analysis for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.. For live market cap and broader valuation context, see Oncosem Onkolojik Sistemler Sanayi ve Ti (ONCSM) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (TRY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.01x | TL53.09 Million | TL52.69 Million | TL26.02 Million | ▲ +38.0% |
| 2021 | 0.73x | TL37.73 Million | TL51.68 Million | TL0.00 | ▼ -12.7% |
| 2020 | 0.84x | TL16.23 Million | TL19.41 Million | TL0.00 | — |